Treatment-related myelodysplastic syndrome after temozolomide for recurrent high-grade glioma

By Su Ying-Wen   Chang Ming-Chih   Chiang Ming-Fu   Hsieh Ruey-Kuen  

Journal of Neuro-Oncology, Vol. 71, Iss. 3, 2005-02 ,pp. : 315-318

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of temozolomide in children with recurrent high-grade glioma

By Ruggiero A.   Cefalo G.   Garré M.L.   Massimino M.   Colosimo C.   Attinà G.   Lazzareschi I.   Maurizi P.   Ridola V.   Mazzarella G.   Caldarelli M.   Rocco C.   Madon E.   Abate M.E.   Clerico A.   Sandri A.   Riccardi R.  

Journal of Neuro-Oncology, Vol. 77, Iss. 1, 2006-03 ,pp. : 89-94

Springer Publishing Company

Access to resources Recommend Favorite

Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas

By Pouratian Nader   Gasco Jaime   Sherman Jonathan   Shaffrey Mark   Schiff David  

Journal of Neuro-Oncology, Vol. 82, Iss. 3, 2007-05 ,pp. : 281-288

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of sunitinib malate in patients with recurrent high-grade glioma

By Neyns B.   Sadones J.   Chaskis C.   Dujardin M.   Everaert H.   Lv S.   Duerinck J.   Tynninen O.   Nupponen N.   Michotte A.   Greve J.  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 491-501

Springer Publishing Company

Access to resources Recommend Favorite

Durable response of a radiation-induced, high-grade cerebellar glioma to temozolomide

By Monje Michelle   Ramakrishna Naren   Young Geoffrey   Drappatz Jan   Doherty Lisa   Wen Patrick   Kesari Santosh  

Journal of Neuro-Oncology, Vol. 84, Iss. 2, 2007-09 ,pp. : 179-183

Springer Publishing Company

Access to resources Recommend Favorite